Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Study to Assess Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis
Phase of Trial: Phase III
Latest Information Update: 04 Dec 2019
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Lidocaine/prilocaine; Nitrous-oxide/oxygen
- Indications Raynaud's disease
- Focus Therapeutic Use
- Acronyms BRASS
- 02 Dec 2019 Planned End Date changed from 30 Apr 2021 to 13 Sep 2020.
- 02 Dec 2019 Planned primary completion date changed from 1 Feb 2021 to 1 Feb 2020.
- 13 Nov 2018 Status changed from not yet recruiting to recruiting.